猫类莱什曼病:基于证据的治疗方法 - - 需要解决的挑战
Caroline de Jesus Sousa1,2,3,4, Joilson Ferreira Batista3,5, Amanda Karoliny Figueredo Brito1,4
1Programa de Pós-Graduação Tecnologias Aplicadas a Animais de Interesse Regional (PPGTAIR), Universidade Federal do Piauí (UFPI), Teresina, Piauí, Brasil.
Current medicinal chemistry
|May 29, 2024
概括
猫类莱什曼病是一种寄生性疾病,在猫身上提出了诊断和治疗的挑战. 虽然传统的治疗方法可以减少寄生虫负载并改善症状,但一致的坚持对于成功至关重要.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
背景情况:
- 莱什曼病是一种被忽视的热带疾病,由莱什曼病寄生虫引起,由传播.
- 猫被越来越多地认为是雷什曼病的潜在储存库,表现出各种临床症状.
- 由于非特异性症状和有限的诊断测试特异性,诊断猫类莱什曼病是具有挑战性的.
研究的目的:
- 审查猫类莱什曼病例,重点关注临床表现,诊断,治疗和结果.
- 为了突出治疗这种寄生虫感染猫的复杂性和变异性.
主要方法:
- 从现有文献中对24例已记录的猫类莱什曼病例进行系统审查.
- 分析临床症状,诊断方法,治疗方案和治疗结果.
主要成果:
- 在12例病例中成功治疗 (没有复发,寄生虫负载减少,症状改善).
- 三个病例最初有良好的反应,但持续的后果;两个病例在初步成功后复发.
- 七个病例没有反应,导致安乐死;传统治疗可能会引起副作用,但可以提高预期寿命.
结论:
- 猫类莱什曼病的常规治疗方法在减少寄生虫负载和改善临床症状方面是有效的.
- 始终坚持治疗至关重要;中断可能导致治疗失败和寄生虫耐药性.
- 需要新的策略来克服治疗挑战,并确保对猫类莱什曼病的持续有效性.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


